Rutgers will provide COVID antibody testing for more than 2,000 children as part of an initiative to determine the incidence of long-term COVID-19 in children.
The process has the potential to lower the cost and improve the reliability of vaccines and biological medications that are temperature-sensitive, including several cancer therapies.